SLC35C1 and malignant colon neoplasm: It is first cloned from leucocyte adhesion deficiency II (LAD II) patients, who showed reduced GDP‐fucose transported into Golgi.19 In the current study, we aim to discover the mechanism of how SLC35C1 regulates the canonical Wnt pathway in colon cancer.